Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-β2-glycoprotein I and anti-annexin A5 antibodies

Rheumatology

Volumn 46, Issue 1, 2007, Pages 81-86

  Gaspersic N ^a   Ambrozic A ^a   Bozic B ^a   Majhenc, J ^b   Svetina, S ^b   Rozman, B ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Annexin A5; Anti 2 glycoprotein I; Anti annexin A5; Giant phospholipid vesicles

Indexed keywords

2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; 2 OLEOYL 1 PALMITOYLPHOSPHATIDYLSERINE; BETA2 GLYCOPROTEIN 1; CALCIUM ION; IMMUNOGLOBULIN G; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

AQUEOUS SOLUTION; ARTICLE; BINDING COMPETITION; BINDING SITE; BLOOD CLOTTING; CASE REPORT; CELL SURFACE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; FLUORESCENCE ANALYSIS; FLUORESCENCE MICROSCOPY; HUMAN; HYPOTHESIS; PATHOGENESIS; PHASE CONTRAST MICROSCOPY; PHOSPHOLIPID MEMBRANE; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOSIS;

ANNEXIN A5; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BINDING, COMPETITIVE; CALCIUM; CELL MEMBRANE; HUMANS; IMMUNOGLOBULIN G; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; PHOSPHOLIPIDS;

EID: 33845568086     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel200     Document Type: Article

References (41)

1. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999;42:1309-11.
2. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other a»ntiphospholipid« autoantibodies. Blood 1994;84:2854-67.
3. 2-glycoprotein I cofactors for antiphospholipid antibodies. Lupus 1996;5:388-92.
4. Reutelingsperger CPM, van Heerde WL. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. CMLS 1997;53:527-32.
5. Van Heerde WL, de Groot PG, Reutelingsperger CPM. The complexity of the phospholipid binding protein annexin V. Thromb Haemost 1995;73:172-9.
6. Krikun G, Lockwood CJ, Wu XX et al. The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalisation and in vitro regulation. Placenta 1994;15:601-12.
7. Kaetzel MA, Hazarika P, Dedman JR. Differential tissue expression of three 35-kDa annexin calcium-dependent phospholipid-binding proteins. J Biol Chem 1989;264:14463-70.
8. Flaherty MJ, West S, Heimark RL. Placental anticoagulant protein I: measurement in extracellular fluids and cells of the hemostatic system. J Lab Clin Med 1990;115:174-9.
9. Chollet P, Malecaze F, Hullin F et al. Inhibition of intraocular fibrin formation with annexin V. Br J Ophthalmol 1992;76:450-2.
10. Van Ryn-McKenna J, Merk H, Müller TH, Buchanan MR, Eisert WG. The effects of heparin and annexin V on fibrin accretion after injury in the jugular veins of rabbits. Thromb Haemost 1993;69:227-30.
11. Van Heerde WL, Sakariassen KS, Hemker HC, Sixma JJ, Reutelingsperger CP, de Groot PG. Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions. Arterioscler Thromb 1994;14:824-30.
12. Rand JH, Wu XX, Guller S et al. Reduction of annexin V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171:1566-72.
13. Thiagarajan P, Benedict CR. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation 1997;96:2339-47.
14. Ravassa S, Bennaghmouch A, Kenis H et al. Annexin A5 downregulates surface expression of tissue factor: A novel mechanism of regulating the membrane receptor repertoire. J Biol Chem 2005;280:6028-35.
15. Rand JH, Wu XX. Antibody-mediated disruption of the annexin-V antithrombotic shield: A new mechanism for thrombosis in the antiphospholipid syndrome. Thromb Haemost 1999;82:649-55.
16. Wang X, Campos B, Kaetzel MA, Dedman JR. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 1999;180:1008-16.
17. Rand JH, Wu XX, Andree HAM et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 1997;337:154-60.
18. Nakamura N, Ban T, Yamaji K, Yoneda Y, Wada Y. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset. J Clin Invest 1998;101:1951-9.
19. Rote NS, Kumar N, Chang SH, Liln L, Xu B, Kent MN. Monoclonal antibody against annexin V prevents intertrophoblast fusion. Lupus 2002;11:564.
20. Sammaritano LR, Gharavi AE, Soberano C, Levy RA, Lockshin MD. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. J Clin Immunol 1992;12:27-35.
21. Andree HAM, Stuart MCA, Hermens WT et al. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 1992;267:17907-12.
22. Rand JH. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: A thrombogenic mechanism for the antiphospholipid syndrome. J Autoimmun 2000;15:107-11.
23. Willems GM, Janssen MP, Comfurius P, Galli M, Zwaal RFA, Bevers EM. Competition of annexin V and anticardiolipin antibodies for binding to phosphatidylserine containing membranes. Biochemistry 2000;39:1982-89.
24. 2-glycoprotein I antibodies. Biochim Biophys Acta 2005;1740:38-44.
25. Božič B, Kveder T, Stegnar M et al. Influence of degraded phosphatidylserine on binding of antiphospholipid antibodies. Int Arch Allerg Immunol 1997;112:19-26.
26. 2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatol 2001;40:565-73.
27. Atsumi T, Ieko M, Bertolaccini ML, Matsuura E, Koike T. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000;43:1982-93.
28. Ambrožič A, Kveder T, Žigon P, Božič B. A modified ELISA for the detection of phosphatidylserine dependent anti-prothrombin antibodies with increased sensitivity and specificity. Ann Rheum Dis 2002;61(Suppl 1):218.
29. Matsubayashi H, Arai T, Izumi S, Sugi T, McIntyre JA, Makino T. Anti-annexin V antibodies in patients with early pregnancy loss or implantations failures. Fertil Steril 2001;76:694-9.
30. Bio-Rad protein assay. For research use only. München, West Germany: Bio-Rad Laboratories, 1989;9-10.
31. Angelova MI, Soleau S, Méléard P, Faucon JF, Bothorel P. Preparation of giant vesicles by external AC electric fields. Kinetics and applications. Prog Colloid Polym Sci 1992;89:127-31.
32. Product information sheet. Annexin V conjugates for apoptosis detection. Molecular Probes 2001.
33. 2-glycoprotein I ELISA: Methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards. Clin Chem Lab Med 2000;38:777-83.
34. McNally TIJ, MacKie DA, Isenberg SJ. Machin, immunoelectrophoresis and ELISA techniques for assay of plasma-beta(2) glycoprotein-I and the influence of plasma lipids. Thromb Res 1993;72:275-86.
35. Polz E, Kostner GM. Binding of beta 2-glycoprotein-I to human serum lipoproteins-distribution among density fractions. FEBS Lett 1979;102:183-6.
36. Rand JH, Wu XX, Quinn AS et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers. Evidence from atomic force microscopy and functional assay. Am J Path 2003;163:1193-200.
37. Tomer A. Antiphospholipid antibody syndrome: Rapid, sensitive, and specific flow cytometric assay for determination of antiplatelet phospholipids autoantibodies. J Lab Clin Med 2002;139:147-54.
38. Mally M, Majhenc J, Svetina S, Žekš B. Mechanisms of equinatoxin II-induced transport through the membrane of a giant phospholipids vesicle. Biophys J 2002;83:944-53.
39. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant α (VAC α) to planar phospholipid bilayers. J Biol Chem 1990;265:4923-8.
40. Reddel SW, Wang YX, Krilis SA. Anti-β2-glycoprotein I autoantibodies require an antigen density threshold, consistent with bivalent binding. Lupus 2003;12:37-45.
41. Božič B, Irman Š, Gašperšič N, Kveder T, Rozman B. Antibodies against annexin A5: Detection pitfalls and clinical associations. Autoimmunity 2005;38:425-30.